In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Alto Neuroscience Inc (NYSE: ANRO) closed the day trading at $11.23 down -7.72% from the previous closing price of $12.17. In other words, the price has decreased by -$7.72 from its previous closing price. On the day, 0.76 million shares were traded. ANRO stock price reached its highest trading level at $11.81 during the session, while it also had its lowest trading level at $10.2.
Ratios:
For a better understanding of ANRO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.43 and its Current Ratio is at 18.43. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on September 29, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
On October 23, 2024, Wedbush Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $29 to $4.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANRO now has a Market Capitalization of 347106848 and an Enterprise Value of 181794544.
Stock Price History:
The Beta on a monthly basis for ANRO is 3.10, which has changed by 2.0810127 over the last 52 weeks, in comparison to a change of 0.15566266 over the same period for the S&P500. Over the past 52 weeks, ANRO has reached a high of $15.18, while it has fallen to a 52-week low of $1.60. The 50-Day Moving Average of the stock is 76.68%, while the 200-Day Moving Average is calculated to be 200.61%.
Shares Statistics:
Over the past 3-months, ANRO traded about 1.49M shares per day on average, while over the past 10 days, ANRO traded about 764420 shares per day. A total of 27.07M shares are outstanding, with a floating share count of 23.85M. Insiders hold about 11.91% of the company’s shares, while institutions hold 81.98% stake in the company. Shares short for ANRO as of 1760486400 were 2248165 with a Short Ratio of 1.51, compared to 1757894400 on 1641280. Therefore, it implies a Short% of Shares Outstanding of 2248165 and a Short% of Float of 10.5399996.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 1 analysts currently analyzing and rating the stock of Alto Neuroscience Inc (ANRO).The consensus estimate for the next quarter is -$0.6, with high estimates of -$0.6 and low estimates of -$0.6.
Analysts are recommending an EPS of between -$2.31 and -$2.88 for the fiscal current year, implying an average EPS of -$2.46. EPS for the following year is -$2.29, with 1 analysts recommending between -$2.29 and -$2.29.
